183 related articles for article (PubMed ID: 23414410)
1. SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier.
Kawano M; Matsui M; Handa H
Expert Rev Vaccines; 2013 Feb; 12(2):199-210. PubMed ID: 23414410
[TBL] [Abstract][Full Text] [Related]
2. Induction of adaptive immune responses against antigens incorporated within the capsid of simian virus 40.
Saika K; Kato M; Sanada H; Matsushita S; Matsui M; Handa H; Kawano M
J Gen Virol; 2020 Aug; 101(8):853-862. PubMed ID: 32501197
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
[TBL] [Abstract][Full Text] [Related]
4. Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the minor capsid proteins VP2/3.
Inoue T; Kawano MA; Takahashi RU; Tsukamoto H; Enomoto T; Imai T; Kataoka K; Handa H
J Biotechnol; 2008 Mar; 134(1-2):181-92. PubMed ID: 18243389
[TBL] [Abstract][Full Text] [Related]
5. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
6. Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants.
Kawano M; Morikawa K; Suda T; Ohno N; Matsushita S; Akatsuka T; Handa H; Matsui M
Virology; 2014 Jan; 448():159-67. PubMed ID: 24314646
[TBL] [Abstract][Full Text] [Related]
7. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
Arora U; Tyagi P; Swaminathan S; Khanna N
Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of different recombinant rabbit hemorrhagic disease virus-like particles carrying CD8+ T cell epitope from chicken ovalbumin (OVA).
Chen M; Song Y; Fan Z; Jiang P; Hu B; Xue J; Wei H; Wang F
Virus Res; 2014 Apr; 183():15-22. PubMed ID: 24457072
[TBL] [Abstract][Full Text] [Related]
9. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
10. Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus.
Yong CY; Yeap SK; Goh ZH; Ho KL; Omar AR; Tan WS
Appl Environ Microbiol; 2015 Feb; 81(3):882-9. PubMed ID: 25416760
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the carboxyl-terminal region of the SV40 major capsid protein VP1.
Yokoyama N; Kawano MA; Tsukamoto H; Enomoto T; Inoue T; Takahashi RU; Nakanishi A; Imai T; Wada T; Handa H
J Biochem; 2007 Feb; 141(2):279-86. PubMed ID: 17283011
[TBL] [Abstract][Full Text] [Related]
12. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
13. In vitro reconstitution of SV40 particles that are composed of VP1/2/3 capsid proteins and nucleosomal DNA and direct efficient gene transfer.
Enomoto T; Kukimoto I; Kawano MA; Yamaguchi Y; Berk AJ; Handa H
Virology; 2011 Nov; 420(1):1-9. PubMed ID: 21917285
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of Newcastle disease virus vectors expressing Norwalk virus capsid protein in the presence or absence of VP2 protein.
Kim SH; Chen S; Jiang X; Green KY; Samal SK
Virology; 2015 Oct; 484():163-169. PubMed ID: 26099695
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein.
Chen Z; Li C; Zhu Y; Wang B; Meng C; Liu G
Virus Res; 2012 Oct; 169(1):306-9. PubMed ID: 22940567
[TBL] [Abstract][Full Text] [Related]
16. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
[TBL] [Abstract][Full Text] [Related]
17. Development of recombinant Yarrowia lipolytica producing virus-like particles of a fish nervous necrosis virus.
Luu VT; Moon HY; Hwang JY; Kang BK; Kang HA
J Microbiol; 2017 Aug; 55(8):655-664. PubMed ID: 28752293
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of virus-like particles and pentamers produced by the expression of SV40 capsid proteins in insect cells.
Kosukegawa A; Arisaka F; Takayama M; Yajima H; Kaidow A; Handa H
Biochim Biophys Acta; 1996 May; 1290(1):37-45. PubMed ID: 8645704
[TBL] [Abstract][Full Text] [Related]
19. A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles.
Lattanzi L; Federico M
Vaccine; 2012 Nov; 30(50):7229-37. PubMed ID: 23099330
[TBL] [Abstract][Full Text] [Related]
20. Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.
Azevedo MP; Vlasova AN; Saif LJ
Expert Rev Vaccines; 2013 Feb; 12(2):169-81. PubMed ID: 23414408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
